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Pleomorphic Adenoma Gene 1 Is 
Needed For timely Zygotic Genome 
Activation and early embryo 
Development
elo Madissoon  1, Anastasios Damdimopoulos2, shintaro Katayama1, Kaarel Krjutškov3,4, 
Elisabet einarsdottir1,4, Katariina Mamia5, Bert De Groef  6, outi Hovatta5, Juha Kere  1,7,8 & 
pauliina Damdimopoulou1,5
Pleomorphic adenoma gene 1 (PLAG1) is a transcription factor involved in cancer and growth. We 
discovered a de novo DNA motif containing a PLAG1 binding site in the promoters of genes activated 
during zygotic genome activation (ZGA) in human embryos. This motif was located within an Alu 
element in a region that was conserved in the murine B1 element. We show that maternally provided 
Plag1 is needed for timely mouse preimplantation embryo development. Heterozygous mouse embryos 
lacking maternal Plag1 showed disrupted regulation of 1,089 genes, spent significantly longer time in 
the 2-cell stage, and started expressing Plag1 ectopically from the paternal allele. The de novo PLAG1 
motif was enriched in the promoters of the genes whose activation was delayed in the absence of Plag1. 
Further, these mouse genes showed a significant overlap with genes upregulated during human ZGA 
that also contain the motif. By gene ontology, the mouse and human ZGA genes with de novo PLAG1 
motifs were involved in ribosome biogenesis and protein synthesis. Collectively, our data suggest that 
PLAG1 affects embryo development in mice and humans through a conserved DNA motif within Alu/B1 
elements located in the promoters of a subset of ZGA genes.
Early preimplantation embryo development is dependent on zygotic genome activation (ZGA)1,2. Transcription 
from the newly formed zygotic genome starts gradually already in the one-cell embryo, and a major increase 
in transcriptional output, known as major ZGA, takes place during the 2-cell (2c) stage in mice and during the 
4c-to-8c transition in humans1,2. Both minor and major ZGA are essential for cleavage stage development in the 
mouse3,4 and thus needed for the formation of a blastocyst capable of implanting to the uterine endometrium. 
Therefore, knowledge about the gene expression program during the first stages of embryonic development and 
regulation of ZGA will help discover factors controlling pluripotency, lineage differentiation and fertility. This has 
prompted many studies to map transcriptional programs during preimplantation development5–10.
In order to understand regulation of gene expression, precise knowledge of transcription start sites (TSSs) is 
needed. We have used an RNA-seq technology based on the detection of the 5′ ends of transcripts to map active 
TSSs during the first three days of human preimplantation development11. De novo motif calling using the regions 
around the detected TSSs led to the identification of multiple significant motifs harboring known transcrip-
tion factor binding sites7,11. Here, we studied a de novo motif discovered in these analyses containing a putative 
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binding site for the pleomorphic adenoma gene 1 (PLAG1). PLAG1 encodes a C2H2 zinc finger transcription 
factor and an oncogene that was first characterized in pleomorphic adenomas of the salivary gland12. It belongs to 
the same protein family as the functionally redundant proto-oncogene PLAG-like 2 (PLAGL2) and the imprinted 
tumor suppressor PLAG-like 1 (PLAGL1). Ectopic expression of PLAG1 and PLAGL2 resulting from chromo-
somal translocation events can be found in malignant tumors13. Associations with cancer have been the focus 
of most studies on PLAG family transcription factors and consequently, less is known about their role in normal 
physiology. There are no reports on PLAG family genes in preimplantation embryo development or pluripo-
tency. By using our human embryo transcriptome data set11, Plag1 knockout (KO) mice14, breeding experiments, 
single-embryo RNA-seq, and time-lapse analysis of cleavage stage embryo development we show that PLAG1 
controls a subset of ZGA genes and is needed for normal cleavage stage embryo development.
Results
A de novo motif containing a PLAG1 binding site is found in the promoters of human ZGA 
genes. Analysis of the TSSs upregulated during major ZGA in human embryos revealed a significant 31-bp de 
novo DNA motifs harboring a known PLAG1 binding site (Fig. 1a)11. This de novo PLAG1 motif was present in 
74 of the 129 promoters upregulated during ZGA and highly similar sites were found in additional 19 promoters 
(Fig. 1b and File S1). The de novo PLAG1 motif was located within a conserved region of an Alu element in close 
vicinity to an RNA polymerase III promoter A-box, and it also partially overlapped with the PRD-like transcrip-
tion factor motif that we identified in our previous study (Fig. 1c; File S1)11. Alu elements are primate-specific 
retrotransposable short interspersed nuclear elements (SINEs) that evolved from a duplication of the 7SL RNA 
gene15 and their evolutionary counterparts in rodents are the B1 elements16. Interestingly, the de novo PLAG1 
motif resided within a segment of the Alu element that was well conserved in the rodent B1 element (Fig. 1c). 
The PLAG1 binding site within the Alu and B1 elements was nearly identical to the PLAG1 consensus site17 
(Fig. 1c). Human and mouse PLAG1 have identical DNA binding domains (Fig. S1). These observations suggest 
that PLAG1 could be involved in human and mouse ZGA through binding to conserved motifs within Alu and 
B1 elements.
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Figure 1. A De Novo DNA Motif Containing a PLAG1 Binding Site Is Found in the Promoters of Human 
ZGA Genes. (a) Comparison of (iv) the database PLAG1 binding site (JASPAR MA0163.1) and (ii) the de 
novo PLAG1 motif. (b) Location of source sites for the de novo PLAG1 motifs (red dots) and similar sites 
(yellow dots) in the promoters of human ZGA genes. Promoters of the 93 genes containing the motifs are 
stacked and aligned ranging from 2,000 upstream to 500 downstream bases around transcription start site 
(TSS, dashed line). The genes are listed in File S1. Locations of AluJ, AluS and AluY elements are highlighted 
in grey. The curve on top of the figure illustrates the density of the de novo PLAG1 motif along the promoter. 
(c) Comparisons of (i) the PRD-like transcription factor de novo motif, (ii) the de novo PLAG1 motif, (iii) 
the known PDR-like transcription factor binding site, (iv) the known PLAG1 binding site (JASPAR), and (v) 
the reported consensus PLAG1 binding site17 with human and mouse short interspersed nuclear elements 
(SINEs). The consensus motif (v) is described by IUPAC notation in which R is a G or A, and K is G or T. The 
internal RNA polymerase III promoter, A-box, is indicated. The de novo motifs and binding motifs are reverse-
complemented. Sequences of AluY, AluSz, AluJo, FLAM_C, 7SLRNA, PB1 and B1_Mm were extracted from the 
Dfam database of repetitive DNA elements. ZGA, zygotic genome activation; TF, transcription factor.
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Plag1 deficiency affects reproductive success but not ovarian or uterine function. To study the 
role of PLAG1 in fertility and ZGA, Plag1 KO mice were obtained. The original phenotype was described on 
the Swiss Webster background whereas our colony was on the CD-1 strain, so we started by studying the repro-
ductive phenotype. Pups from heterozygous intercrosses (HET × HET) did not significantly deviate from the 
expected Mendelian distribution, although 43% fewer KO pups were born than expected (Fig. 2a). KO pups were 
41% smaller than wildtype (WT) at weaning, as reported before (Fig. 2b)14. Litter frequency over a three-month 
continuous breeding period did not differ between HET × HET crosses and pairs consisting of a KO female 
and a HET male (Fig. 2c). However, KO males with HET females did not manage to maintain the approximate 
one litter-per-month rate (Fig. 2c). KO × KO intercrosses had significantly reduced litter frequency: the three 
KO × KO breeding pairs produced only two litters in total during the entire three-month test period (Fig. 2c).
Litter size was affected in couples with KO mothers (Fig. 2d)14. Breeding pairs with a KO female and a HET 
male produced significantly fewer pups per litter, whereas litter size was normal if the parental genotypes were 
reversed (HET female × KO male) (Fig. 2d). Homozygous KO × KO crosses produced the smallest litters 
(Fig. 2d). The significant reduction in litter size was seen as early as 7.5–8.5 days post coitum (dpc), when fewer 
implantation marks were observed in KO uteri as compared to HET and WT mothers (Fig. 2e,f). This did not 
depend on ovarian function, as neither oocyte yield in response to gonadotropin-induced superovulation or ovar-
ian follicle counts differed between WT and KO females (Fig. S2a–d). All normal uterine structures were pres-
ent in KO females, and body-weight adjusted uterine weights did not differ between the genotypes (Fig. S2e,f). 
RNA-seq performed on uterine horns, endometrial mucosa and myometrial samples did not reveal differences 
in transcriptomes between genotypes (Fig. S2g). Taken together, these data show that Plag1 KO females have no 
significant defects in their ovaries and uteri and reproduce with normal frequency, but produce significantly fewer 
pups per litter as compared to HET and WT females.
Maternal Plag1 knockout leads to delayed 2-cell stage embryo development, disrupted gene 
expression, and ectopic expression of paternal Plag1. We next studied embryos. Since Plag1 KO 
females had small litters regardless of the paternal genotype, we focused on the maternal Plag1 effect and studied 
embryos derived from Plag1 KO females crossed with WT males. These breeding pairs produced HET embryos 
that lack the maternal Plag1 allele, and will hereafter be referred to as matPlag1KO embryos.
Preimplantation development of 53 WT and 75 matPlag1KO embryos was analyzed by time-lapse microscopy 
from zygote to late morula during three independent imaging sessions, each of which contained both genotypes 
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Figure 2. PLAG1 Deficiency Affects Growth and Reproduction in Mice. (a) Observed and expected numbers 
of pup genotypes in litters from Plag1 heterozygote intercrosses. (b) Body weights of female and male pups 
at weaning (3-weeks-old). (c) Frequency of litters from breeding pairs of different genotypes maintained in 
continuous breeding for 90 days. Every breeding pair is represented with a horizontal line and the birth of a litter 
is illustrated with a circle. Quantification of the data is shown on the right. (d) Mean number of pups in litters 
from different parent genotypes. (e) Mean number of implanted embryos on 7.5–8.5 dpc. (f) Representative 
photos of uteri at dissection. Asterisks indicate implanted embryos. Scale bars are 1 cm. The data in b–e are 
presented as means + SEM and the number of observations is shown inside the columns. Statistical analysis by 
χ2 test (a) or one-way ANOVA followed by Fisher LSD post-hoc test (b−f). *p < 0.05, **p < 0.01, ***p < 0.001. F, 
female; HET, heterozygote; KO, knockout; M, male; WT, wildtype.
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(Videos S1 and S2). We discovered that matPlag1KO embryos spent significantly more time in the 2c stage com-
pared to WT embryos (Fig. 3a). When 50% of WT embryos had already proceeded to the 4c stage, 100% of mat-
Plag1KO embryos were still arrested at the 2c stage (Fig. 3a, arrow). On average, matPlag1KO embryos spent 3 h 
longer in 2c stage compared to WT. The survival of the embryos did not differ between genotypes: 60% of the WT 
zygotes and 73% of matPlag1KO zygotes developed to a morula.
Next, altogether 45 WT and 45 matPlag1KO oocytes and embryos representing three developmental stages 
(oocytes, 2c stage and 8c stage) were collected for single-embryo RNA-seq (Fig. 3b). Spike-in RNA was used for 
data normalization to correct for the large general changes in cellular RNA content during preimplantation devel-
opment (Fig. S3). The majority of differentially expressed genes (DEGs) were downregulated in oocyte-to-2c stage 
transition in both WT (6,823 DEGs down vs 2,910 up) and matPlag1KO (6,044 DEGs down vs 2,851 up) embryos 
reflecting degradation of maternal transcripts (Fig. 3c). More DEGs were upregulated in the 2c–8c transition, 
when the zygotic genome becomes fully active (3,636 DEGs up in WT and 3,586 in matPlag1KO) (Fig. 3c).
The largest difference between WT and matPlag1KO embryos was found at the 2c stage when matPlag1KO 
embryos had 530 downregulated and 559 upregulated DEGs compared to WT, suggesting a dysregulation of 
approximately 11% of all genes regulated during the oocyte-to-2c transition (Fig. 3c,d). The differences were also 
clearly detected in different clustering analyses. Heatmap clustered the embryos into three primary groups by 
developmental stage (oocyte, 2c, 8c) but also by genotype at the 2c stage (Fig. 3e). Principal component analysis 
likewise separated the embryos primarily by developmental stage and by genotype at the 2c stage (Fig. 3f). Cell 
trajectory analysis yielded the same result and further suggested that the transcriptional program in the mat-
Plag1KO embryos lagged behind the WT at the 2c stage (Fig. 3g).
The expression pattern of the dysregulated DEGs in 2c matPlag1KO embryos was studied by plotting their 
mean expression levels from oocyte to the 8c stage. DEGs upregulated in matPlag1KO embryos compared to WT 
were actually maternally loaded transcripts whose degradation was delayed (Fig. 4a). Similarly, the DEGs down-
regulated in matPlag1KO embryos at the 2c stage were in fact genes whose upregulation was delayed (Fig. 4a). 
We hereafter refer to these two sets of genes as “delayed-degradation” and “delayed-activation” genes. By the 8c 
stage, their expression levels had reached the WT levels (Fig. 4a). Plag1 transcripts were present in WT oocytes 
but absent in KO oocytes (Fig. 4b). In WT embryos, the maternally provided Plag1 was completely degraded by 
the 2c stage and remained absent in 8c embryos, suggesting that Plag1 is normally not expressed from the zygotic 
genome (Fig. 4b). Interestingly, in clear contrast to WT embryos, matPlag1KO embryos expressed Plag1 in the 2c 
stage. As these embryos lack maternal Plag1 allele, the expression must stem from activation of the paternal allele. 
This ectopic expression of Plag1 in the 2c stage matPlag1KO embryos returned to baseline by 8c stage (Fig. 4b), 
when also the delayed-activation and delayed-degradation genes had caught up with the WT expression levels 
(Fig. 4a). This may suggest rescue of the ZGA by paternal Plag1 expression. Factors that are needed for ZGA are 
maternally provided into the oocyte during folliculogenesis. Our data shows that Plag1 transcripts were mater-
nally provided into mouse oocytes (Fig. 4b) and they were already present during folliculogenesis (Fig. S5). In 
addition, analysis of two independent human RNA-seq datasets showed that PLAG1 is maternally provided to 
human oocytes as well with decreasing levels towards blastocyst stage (Fig. S4).
Gene ontology analyses showed that the delayed-activation genes belong into categories relevant to ribosome 
biogenesis, RNA processing, and translation, whereas the delayed-degradation genes clustered to diverse GO cat-
egories ranging from neurogenesis to negative regulation of transcription (Fig. 4c, File S2). The delayed-activation 
GOs showed higher similarity to genes typically upregulated during 2c–8c transition in WT embryos (best-match 
average (BMA) 0.792) than to those downregulated (BMA 0.531) (File S3). Conversely, the delayed-degradation 
GOs showed higher similarity to genes normally downregulated between 2c–8c stages (BMA 0.714) than to those 
upregulated (BMA 0.445) (File S3). These data confirmed that embryos that lacked the maternal Plag1 were char-
acterized by delayed transition through the 2c stage due to specific sets of genes being dysregulated compared to 
WT embryos.
The delayed-activation genes overlap with human ZGA genes and have enriched PLAG1 de 
novo motif in their promoters. We next wanted to compare our current mouse embryo data with our 
earlier human embryo transcriptome data11, and converted the mouse genes to human orthologues. The gene 
expression changes during major ZGA in humans (4c–8c transition) and WT mice (2c–8c transition) were highly 
similar in general between our datasets (Fig. S6). A gene set analysis showed that the genes upregulated during 
human major ZGA were significantly enriched among the mouse delayed-activation genes (Fig. 5a). The same 
result was obtained using the χ2 test; a significant overlap was found between the human major ZGA genes with 
the matPlag1KO delayed-activation genes but not with the delayed-degradation genes (Fig. 5b). Comparison of 
protein families yielded similar results (Fig. 5c).
We then studied the occurrence of the database PLAG1 binding sites and the de novo PLAG1 motifs in the 
affected mouse gene promoters. Database PLAG1 binding sites were found in less than 10% of the promoters 
in general, and surprisingly the occurrence was significantly lower in the promoters of the delayed-activation 
genes (5.5%) (Fig. 5d). However, the results were the opposite when we used our de novo PLAG1 motif instead. 
A significantly higher proportion of the delayed-activation promoters contained at least one de novo PLAG1 
motif (31.5%) compared to “expressed but not affected” (21.5%) and delayed-degradation (19.3%) genes (Fig. 5d, 
File S4). We also studied the connection of these de novo PLAG1 motifs to B1 elements and obtained virtually 
identical results, showing that the vast majority of the de novo PLAG1 motifs reside within B1 elements (Fig. 5d). 
In addition to occurrence (present or not), we also considered the frequency (how many) of the de novo PLAG1 
motifs. A significantly higher frequency was found in the promoters of delayed-activation genes compared to 
delayed-degradation genes (Fig. S7).
Finally, we compared the homologous mouse delayed-activation and human ZGA genes that contained at least 
one de novo PLAG1 motif and found a significant overlap (Fig. 5e). We GO-annotated the three gene groups, i.e. 
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Figure 3. Maternal Plag1 Knockout Leads to Delayed 2-cell stage Embryo Development and Disrupted 
Embryonic Gene Expression. (a) WT and matPlag1KO zygotes were collected for ex vivo imaging through time-
lapse microscopy and cleavage stage developmental timing was recorded manually for each embryo. Plots show 
the empirical cumulative distribution function (y-axis, 0–1) of embryos that have exited the corresponding 
developmental stage at each time point (x-axis, hours). Significance between WT (N = 53) and matPlag1KO 
(N = 75) embryo developmental timing was tested using the Kolmogorov-Smirnov test and p-values are shown 
in the plots. Average time spent in the stage (SEM) is also shown. (b) WT and matPlag1KO MII oocytes, 
2-cell stage and 8-cell stage embryos were collected for single-embryo RNA-seq. The timing of hormonal 
treatments, WT embryo development and embryo collection time points are shown together with the numbers 
of embryos sequenced (numbers of donor females in brackets). (c) Number of differentially expressed genes 
from one developmental stage to another (horizontal arrows) in matPlag1KO and WT embryos. (d) Number 
of differentially expressed genes between matPlag1KO and WT embryos at the MII oocyte, 2c and 8c stage. 
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human ZGA, mouse delayed-activation and mouse-delayed degradation genes. Hierarchical clustering revealed 
that human ZGA and mouse delayed-activation genes clustered together to categories representing ribosomes, 
protein transport, translation, RNA processing, and protein metabolism, whereas mouse delayed-degradation 
genes showed little overlap with the human ZGA clusters (Fig. 5f). These data suggest that mouse and human 
embryos have a functionally conserved set of genes that is activated during ZGA and contain PLAG1 binding sites 
within repetitive elements in their promoters.
Discussion
In the present study, we have discovered a new role for the oncogene PLAG1 in the regulation of ZGA. We iden-
tified a de novo assembled motif containing a PLAG1 binding site among the promoters upregulated during 
ZGA in human embryos, and showed that the lack of maternally loaded Plag1 in mouse oocytes lead to a signif-
icant delay in ZGA on a transcriptional level with consequences for the timing of cleavage-stage development. 
Restoration of gene expression levels and embryo developmental speed coincided with ectopic expression of 
Plag1 from the paternal allele. These data imply a functional role for PLAG1 in the regulation of ZGA. Our data 
further propose that PLAG1 target genes have roles in central cellular processes that relate to ribosomes, RNA and 
protein metabolism, which undoubtedly have an essential function during early embryo growth.
We show that matPlag1KO embryos that lack the Plag1 transcript only during the first hours following fertili-
zation spent significantly longer time in the 2c stage compared to WT embryos. The 2c stage is the developmental 
stage when the major ZGA takes place in the mouse, and failure to activate transcription leads to developmen-
tal arrest3. Embryo development can be affected by single genes. For example, knockdown of the pluripotency 
factor Lin28 in mouse embryos leads to arrest at the 2c–4c stage18, and KO of the maternal-effect gene Mater to 
arrested embryonic development at the 2c stage19. At the 2c stage, when the development of every studied mat-
Plag1KO embryo was delayed compared to WT, these embryos started expressing Plag1 from the paternal allele. 
This upregulation was followed by regaining the normal developmental pace as well as normal transcriptomic 
program by the 8c stage, suggesting that the ectopic paternal expression of Plag1 rescued the embryo phenotype. 
Although these data argue that Plag1 is essential for embryo development at the 2c stage, we noted that even 
homozygous Plag1 KO intercrosses occasionally produced litters, showing that a complete lack of Plag1 is not 
strictly lethal to the embryos. Analysis of embryos from KO × KO breedings would help to understand the preim-
plantation phenotype. Unfortunately, the extremely poor breeding success of the KO × KO couples renders these 
studies unpractical. We further hypothesize that Plagl2, the Plag1 -family member with redundant functions to 
Plag1 that is also maternally provided, might rescue embryo development in some cases. Testing this hypothesis 
would require generation of Plag1/Plagl2 double KO mice, which is impossible due to the severe phenotype of 
Plagl2 KO mice; KO pups die shortly after birth to starvation due to their inability to absorb chylomicrons20.
Although matPlag1KO embryos regained a normal developmental pace after exiting the 2c stage, their devel-
opmental success was not the same as that of WT embryos, as evidenced by the reduced number of implantation 
sites and smaller litter size. Our embryo time-lapse data do show that matPlag1KO embryos developed to the 
blastocyst stage with equal efficiency as WT embryos. Since KO uteri already showed less implantation marks at 
7.5−8.5 dpc, the embryo loss must occur sometime between 4.5 and 7.5 dpc, i.e., when the blastocyst normally 
implants or shortly thereafter. Developmental competence of human embryos can be scored after in vitro fertiliza-
tion through morphokinetic measurements, and the time an embryo spends in the 2c and 4c stages is a significant 
determinant of developmental potential21. Following this, we hypothesize that the delayed 2c stage development 
and associated dysregulation of over 1,000 genes in matPlag1KO embryos could have adverse effects on the over-
all developmental potential of the blastocysts. In addition, synchronous preparation of both the embryo and 
endometrium for implantation is a prerequisite for successful implantation during the window of receptivity. 
Therefore, a simple delay in preimplantation development could contribute to some blastocysts missing this crit-
ical window22.
The de novo PLAG1 motif frequently localized within repetitive elements in the promoters of the ZGA genes. 
Alu elements are transposable elements ubiquitously present in primate genomes with involvement in gene reg-
ulation through various mechanisms23 and their counterparts in the mouse genome are B1 elements16. Despite 
independent evolution for over 80 million years, the densities of Alu and B1 elements in promoters of ortholo-
gous genes in humans and mice are surprisingly correlated15,24,25. In particular, Alu and B1 elements are highly 
enriched in promoters that are activated during ZGA26. The fact that the region that contains the PLAG1 binding 
site is conserved within the Alu and B1 elements suggests positive evolutionary selection. Collectively, these find-
ings may suggest that Alu and B1 play a role in ZGA in humans and mice by attracting transcription factors such 
as PLAG1 to gene promoters.
The delayed-activation genes were mainly related to ribosome biogenesis, maturation and function by ontol-
ogy. Even when we restricted the analysis to those genes that contained the de novo PLAG1 motif, GO analyses 
suggested roles in ribosome biogenesis and RNA and protein metabolism, both in mice and humans. It has been 
shown that Alu elements are enriched in promoters of genes involved in ribosome biogenesis, protein biosyn-
thesis and RNA metabolism25, and one function could be to attract transcription factors such as PLAG1. Many 
oncogenes have effects on ribosome biogenesis, which enables cancerous cells to increase protein synthesis and 
grow rapidly27. Although PLAG1 is an oncogene, its potential role in ribosome biogenesis and protein synthesis 
has not been investigated. One of the most striking phenotypes of the Plag1 KO mice is their small size14. In 
(e–g) Heatmap (e), principal component analysis (f), and pseudotime (cell trajectory) analysis (g) based on all 
differentially expressed genes in the libraries. 2c, 2-cell stage; 8c, 8-cell stage; DEG, differentially expressed gene; 
hCG, human chorionic gonadotropin; KO, knockout; PC, principal component; WT, wildtype.
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addition, PLAG1 polymorphisms associate with body size and growth in farm animals and humans13,28–31. Based 
on our data, we present a hypothesis that PLAG1-associated growth phenotypes, such as growth retardation in the 
KO mice, results from modulation of protein synthesis that affects cell size and division rate.
We conclude that the lack of maternally provided Plag1 leads to a delay in ZGA manifested as prolonged 2c 
stage development, which is rescued by ectopic paternal Plag1 expression. This delay and associated dysregulation 
of genes needed for ribosome biogenesis, RNA and protein metabolism could lead to reduced embryo compe-
tence for implantation, explaining the reduced litter size in KO mothers. We further propose that the effect of 
PLAG1 on ZGA genes arose through retrotransposition of Alu and B1 elements, where the PLAG1 binding sites 
have been under positive selection. Follow-up studies should focus on a deeper analysis of PLAG1 involvement in 
protein synthesis, as this is a mechanism that would explain many of the reported biological activities of PLAG1, 
including tumorigenicity, cell proliferation, and growth.
Materials and Methods
Detailed materials and methods are provided in the Supplemental Information.
Mouse studies. All experiments were approved by the Swedish Board of Agriculture (#S5–14) and per-
formed in accordance with the ethical licence.
Plag1KO mice14 in CD-1 strain were a kind gift from Prof. Wim Van de Ven (University of Leuven, Belgium) 
and Dr. Carol Schuurmans (University of Calgary, Canada). The colony was established via embryo transfers, 
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maintained as HET breedings, and genotyped using ear punches. To generate oocytes and zygotes for exper-
iments, sexually mature young females were superovulated. Their ovaries and uteri were collected for histol-
ogy and gene expression analysis. For time-lapse microscopy, zygotes (n = 103 matPlag1KO and n = 89 WT) 
were placed into a live-cell imaging incubator under a Nikon Ti-E spinning disk wide-field microscope and 
imaged every 30 min with an Andor EM-CCD camera. The experiment was carried out three times with both 
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genotypes present, and the developmental pace was manually scored from the images by a researcher blinded to 
the genotypes.
To count implantation marks, KO and WT females were mated with trained WT studs and their uteri were 
collected 7.5–8.5 dpc for visual inspection. The experiment was carried out twice, with a total of 8 KO and 8 WT 
females.
RNA expression in uterus samples (n = 8 Plag1KO, n = 8 WT) was measured using STRT RNA-seq protocol32. 
Uterine horns were cut longitudinally, mucosa and myometrium separated by scraping, and the samples stored in 
RNAlater (Ambion, Foster City, CA, USA) until RNA extraction (RNeasy Mini kit, Qiagen, Hilden, Germany). 
Ten nanograms of RNA (RIN > 8) was used for RNA-seq as described32.
RNA expression in single manually picked oocytes and embryos was detected by analyzing two independent 
libraries prepared on three occasions with both genotypes present both times. Modified STRT protocol32 was 
used.
RNA-seq data analysis. RNA-seq data was analyzed as described previously32. Libraries with a median gene 
expression of log2 counts per million (cpm) under 0 were excluded, and cell libraries were normalized with the 
TMM methods using EdgeR33. Differential gene expression analysis using EdgeR was performed on genes that 
had 1 cpm in at least five or more samples. Principal component analysis, heatmaps, hierarchical clustering, cell 
trajectory and GO analyses were carried out using DEGs in R34. Enriched GO terms were identified using Fisher 
statistics and compared via semantic similarity analysis using the Wang algorithm35. Homologene from NCBI was 
used to convert the human genes to the homologous mouse genes, and gene enrichment analyses were carried out 
using geneSetTest function from the limma package36.
Promoter analyses. Human embryo promoter analysis was performed as previously described11. SINE 
repetitive elements were retrieved from the Dfam database37 and aligned in JalView2. Mouse embryo promoter 
analysis was carried out with Homer38. Distance of repetitive elements and de novo PLAG1 motifs to the nearest 
TSS was plotted using ggplot2. Enrichment was analyzed using Fisher’s exact test.
Statistical analysis. Continuous data were analyzed with Student’s t-test, one-way or two-way ANOVA, 
followed by Fisher LSD post-hoc test. Normality was tested with the Shaphiro-Wilks test and homoscedasticity 
with Levene’s test. Categorical data were analyzed with the χ2 test. The exit time of embryos from each develop-
mental stage was plotted as an empirical distribution function (ecdf) using ggplot2 and significance tested using 
the Kolmogorov-Smirnov test. All analyses were carried out using R, the p values are two-tailed and considered 
significant if p < 0.05.
Data Availability
RNA-seq data have been deposited to Gene Expression Omnibus data repository as a SuperSeries record under 
the reference GSE111040.
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